Clinical Trials
10 trialsNCT03011528 2025-11-21
CombinaiR3
Institut Curie
Phase 2 Completed
NCT05051631 2025-08-28
BRAVE
Vanderbilt University Medical Center
Phase NA Completed
NCT00777998 2023-10-27
Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf
Phase 2 Completed
NCT02063685 2022-06-21
Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma
Fondazione Italiana Linfomi - ETS
Phase 3 Completed
NCT02067143 2021-09-08
LAL1913
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed
NCT02027428 2020-08-17
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Celgene
Phase 3 Completed
NCT00580372 2016-09-20
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
University of Arkansas
Phase 2 Completed
NCT00480363 2013-07-31
QUIREDEX
PETHEMA Foundation
Phase 3 Completed
NCT00560053 2008-11-27
Pethema Multiple Myeloma 2000
PETHEMA Foundation
Phase 3 Completed
NCT00599937 2008-01-24
APL93: Timing of CxT and Role of Maintenance
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Phase 3 Completed